Refuerzo, Daicy Mae L.

HRN: 16-74-57  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/06/2023
CEFUROXIME 1.5GM (VIAL)
05/06/2023
05/13/2023
IV
1.5g
Q8hours
UTI
05/07/2023
CEFTRIAXONE 1G (VIAL)
05/07/2023
05/13/2023
IV
2g
Od
Uti
Waiting Final Action 
10/24/2023
CEFUROXIME 500MG (TAB)
10/24/2023
10/31/2023
PO
500mg Tab
BID
Post NSVD
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: